2B4R image
Deposition Date 2005-09-26
Release Date 2005-10-04
Last Version Date 2023-08-23
Entry Detail
PDB ID:
2B4R
Keywords:
Title:
Crystal structure of glyceraldehyde-3-phosphate dehydrogenase from Plasmodium falciparum at 2.25 Angstrom Resolution reveals intriguing extra electron density in the active site
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.25 Å
R-Value Free:
0.24
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:glyceraldehyde-3-phosphate dehydrogenase
Mutations:V3A, N336T N337S
Chain IDs:A (auth: O), B (auth: P), C (auth: Q), D (auth: R)
Chain Length:345
Number of Molecules:4
Biological Source:Plasmodium falciparum
Primary Citation
Crystal structure of glyceraldehyde-3-phosphate dehydrogenase from Plasmodium falciparum at 2.25 A resolution reveals intriguing extra electron density in the active site
Proteins 62 570 577 (2006)
PMID: 16345073 DOI: 10.1002/prot.20801

Abstact

The crystal structure of D-glyceraldehyde-3-phosphate dehydrogenase (PfGAPDH) from the major malaria parasite Plasmodium falciparum is solved at 2.25 A resolution. The structure of PfGAPDH is of interest due to the dependence of the malaria parasite in infected human erythrocytes on the glycolytic pathway for its energy generation. Recent evidence suggests that PfGAPDH may also be required for other critical activities such as apical complex formation. The cofactor NAD(+) is bound to all four subunits of the tetrameric enzyme displaying excellent electron densities. In addition, in all four subunits a completely unexpected large island of extra electron density in the active site is observed, approaching closely the nicotinamide ribose of the NAD(+). This density is most likely the protease inhibitor AEBSF, found in maps from two different crystals. This putative AEBSF molecule is positioned in a crucial location and hence our structure, with expected and unexpected ligands bound, can be of assistance in lead development and design of novel antimalarials.

Legend

Protein

Chemical

Disease

Primary Citation of related structures